4
Changes in Ownership
TriSalus Life Sciences, Inc. Filed Acc 0001104659-20-139621
Options or other derivatives
- Chief Executive Officer disposed of 75,000 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Dewey Christopher C Chief Executive Officer | 2020-12-22 | Other disposition · Class B Common Stock | −75,000 | 6,250,000 | I | ||
Loading xslF345X03/tm2039407d1_4.xml…